Oral antidiabetics improve outcomes in diabetics with colorectal cancer
Bottom Line: Among patients with both colorectal cancer and diabetes in Korea, those who had a high adherence to their oral diabetes medication had a significantly reduced risk of overall mortality compared with those with lower adherence.
.png)
No hay comentarios:
Publicar un comentario